Mount Sinai researchers develop novel method to identify and treat aggressive early-stage lung cancers - EurekAlert

Study is first of its kind to reveal potential impact of aurora kinase inhibitors

Mount Sinai researchers have developed a novel method to identify aggressive early-stage lung cancers and target drugs known as aurora kinase inhibitors to tumors that are especially likely to respon… [+4942 chars]

full article...